Barclays’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-17,800
| Closed | -$939K | – | 4857 |
|
|
2021
Q2 | $939K | Buy |
+17,800
| New | +$885K | ﹤0.01% | 2697 |
|
|
2021
Q1 | – | Sell |
-3,700
| Closed | -$178K | – | 4910 |
|
|
2020
Q4 | $178K | Hold |
3,700
| – | – | ﹤0.01% | 3827 |
|
|
2020
Q3 | $173K | Sell |
3,700
-100
| -3% | -$4.91K | ﹤0.01% | 3929 |
|
|
2020
Q2 | $171K | Sell |
3,800
-9,400
| -71% | -$365K | ﹤0.01% | 4182 |
|
|
2020
Q1 | $385K | Buy |
13,200
+500
| +4% | +$18.6K | ﹤0.01% | 3791 |
|
|
2019
Q4 | $605K | Sell |
12,700
-5,900
| -32% | -$256K | ﹤0.01% | 4126 |
|
|
2019
Q3 | $704K | Sell |
18,600
-15,800
| -46% | -$617K | ﹤0.01% | 3965 |
|
|
2019
Q2 | $1.47M | Sell |
34,400
-7,300
| -18% | -$346K | ﹤0.01% | 3268 |
|
|
2019
Q1 | $2.21M | Buy |
41,700
+4,400
| +12% | +$253K | ﹤0.01% | 2464 |
|
|
2018
Q4 | $2.2M | Buy |
37,300
+16,300
| +78% | +$900K | ﹤0.01% | 2316 |
|
|
2018
Q3 | $1.15M | Sell |
21,000
-800
| -4% | -$44.2K | ﹤0.01% | 3498 |
|
|
2018
Q2 | $1.17M | Sell |
21,800
-54,600
| -71% | -$2.87M | ﹤0.01% | 3107 |
|
|
2018
Q1 | $3.72M | Buy |
76,400
+24,800
| +48% | +$1.05M | ﹤0.01% | 1860 |
|
|
2017
Q4 | $1.75M | Sell |
51,600
-90,200
| -64% | -$3.16M | ﹤0.01% | 2559 |
|
|
2017
Q3 | $4.81M | Buy |
141,800
+42,600
| +43% | +$1.46M | 0.01% | 1559 |
|
|
2017
Q2 | $3.54M | Sell |
99,200
-76,200
| -43% | -$2.57M | ﹤0.01% | 1741 |
|
|
2017
Q1 | $5.1M | Sell |
175,400
-77,200
| -31% | -$2.15M | 0.01% | 1317 |
|
|
2016
Q4 | $6.08M | Buy |
252,600
+56,400
| +29% | +$1.54M | 0.01% | 1265 |
|
|
2016
Q3 | $6.08M | Buy |
196,200
+108,800
| +124% | +$3.44M | 0.01% | 1154 |
|
|
2016
Q2 | $2.56M | Sell |
87,400
-512,200
| -85% | -$15.3M | ﹤0.01% | 1819 |
|
|
2016
Q1 | $18.3M | Buy |
599,600
+345,400
| +136% | +$8.91M | 0.03% | 507 |
|
|
2015
Q4 | $6.74M | Sell |
254,200
-60,800
| -19% | -$1.69M | 0.01% | 1105 |
|
|
2015
Q3 | $8.51M | Sell |
315,000
-46,600
| -13% | -$1.28M | 0.01% | 1033 |
|
|
2015
Q2 | $9.94M | Sell |
361,600
-596,600
| -62% | -$14.4M | 0.01% | 1033 |
|
|
2015
Q1 | $20.1M | Sell |
958,200
-237,400
| -20% | -$4.05M | 0.02% | 674 |
|
|
2014
Q4 | $22.1M | Buy |
1,195,600
+650,000
| +119% | +$13.9M | 0.02% | 706 |
|
|
2014
Q3 | $11.7M | Sell |
545,600
-14,400
| -3% | -$385K | 0.01% | 1061 |
|
|
2014
Q2 | $17.9M | Sell |
560,000
-108,600
| -16% | -$3.33M | 0.02% | 764 |
|
|
2014
Q1 | $19.1M | Sell |
668,600
-619,000
| -48% | -$20.4M | 0.02% | 724 |
|
|
2013
Q4 | $50.2M | Buy |
1,287,600
+180,400
| +16% | +$6.25M | 0.05% | 344 |
|
|
2013
Q3 | $38.2M | Buy |
1,107,200
+319,000
| +40% | +$9.86M | 0.05% | 378 |
|
|
2013
Q2 | $17.8M | Buy |
+788,200
| New | +$16.8M | 0.02% | 708 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
Barclays's HLF Position: Q1 2026 in Review
Barclays reduced its Herbalife (HLF) stake by 88% in Q1 2026, selling an estimated $2.28M and leaving 19,732 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.
Barclays first reported a position in HLF in Q2 2013 and has held it in 51 quarters since. The position peaked at $25M in Q4 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- Barclays held 19,732 shares of Herbalife worth $290K as of Q1 2026.
- Barclays sold 139,868 Herbalife shares in Q1 2026, an estimated $2.28M.
- Herbalife made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3486 holding.
- Barclays first reported a position in Herbalife in Q2 2013 and has held it in 51 quarters since.
- Barclays's Herbalife position peaked at $25M in Q4 2013.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.